Indian Journal of Drugs in Dermatology

ORIGINAL ARTICLE
Year
: 2015  |  Volume : 1  |  Issue : 1  |  Page : 16--18

Topical 2% mupirocin versus 2% fusidic acid versus 1% nadifloxacin cream in the treatment of superficial bacterial infections of the skin


Resham J Vasani1, Sudhir V Medhekar2 
1 Consultant Dermatologist, Anand Polyclinic, Matunga, India
2 Professor and Head of Department, Government Medical College, Aurangabad, India

Correspondence Address:
Resham J Vasani
C 1, 22, Karmakshetra, Near Shanmukhananda Hall, Sion , Mumbai- 37, Maharashtra
India

Introduction: Topical mupirocin, fusidic acid, and nadifloxacin are used in the treatment of superficial bacterial infections. This study was undertaken to assess the efficacy and safety of these three topical antibiotics in the treatment of superficial bacterial infection of the skin. Aims: To compare the efficacy and safety profile of 2% mupirocin versus 2% fusidic acid versus 1% nadifloxacin cream in the treatment of superficial bacterial infections. Materials and Methods: A randomized study in treatment-naive cases of uncomplicated bacterial skin infections attending the out-patient Department of Dermatology was done. A total of 90 patients of bacterial infections of the skin were included, which were randomly allocated to three different study groups. After diagnosis was confirmed clinically, grading of the lesions was done with regard to parameters such as erythema, edema, vesiculation, pustulation, crusting, and scaling. Score was applied to each parameter as 0-absent, 1-mild, 2-moderate, and 3-severe. Gram staining was performed. The lesions were graded on subsequent visits on day 4, day 18, and day 14. The results were subjected to analysis of variance test, followed by the Dunnett's test. Results: Fusidic acid cream showed faster reduction of the scores at the end of the first visit. The differences noted in the efficacy of the three drugs were not statistically significant. No significant side effects were observed. Conclusion: This study documents the equality in the comparative safety and efficacy of mupirocin, fusidic acid, and nadifloxacin in the treatment of uncomplicated superficial bacterial infections at our center.


How to cite this article:
Vasani RJ, Medhekar SV. Topical 2% mupirocin versus 2% fusidic acid versus 1% nadifloxacin cream in the treatment of superficial bacterial infections of the skin.Indian J Drugs Dermatol 2015;1:16-18


How to cite this URL:
Vasani RJ, Medhekar SV. Topical 2% mupirocin versus 2% fusidic acid versus 1% nadifloxacin cream in the treatment of superficial bacterial infections of the skin. Indian J Drugs Dermatol [serial online] 2015 [cited 2020 Jul 5 ];1:16-18
Available from: http://www.ijdd.in/article.asp?issn=2455-3972;year=2015;volume=1;issue=1;spage=16;epage=18;aulast=Vasani;type=0